Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Nike
NKE
5
Palantir
PLTR
HK Stock MarketDetailed Quotes
01488 BEST FOOD HLDG
- 0.960
- +0.070+7.87%
Market Closed Apr 3 16:08 CST
1.52BMarket Cap-5.82P/E (TTM)
0.960High0.940Low12.00KVolume0.940Open0.890Pre Close11.34KTurnover0.00%Turnover RatioLossP/E (Static)1.58BShares1.12052wk High-5.61P/B1.52BFloat Cap0.56052wk Low--Dividend TTM1.58BShs Float2.425Historical High--Dividend LFY2.25%Amplitude0.105Historical Low0.945Avg Price2000Lot Size--Div YieldTTM--Div Yield LFY
BEST FOOD HLDG Key Stats
All
YOY
| (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | (Q6)Jun 30, 2020 | (FY)Dec 31, 2019 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | ---- | 13.18%-158.17M | ---- | 72.63%-182.18M | ---- | -314.27%-665.69M | ---- | -44.27%-160.69M | ---- | -3,343.06%-111.38M |
| Profit adjustment | ||||||||||
| Interest (income) - adjustment | ---- | -71.62%-381K | ---- | 77.09%-222K | ---- | -4.64%-969K | ---- | 68.39%-926K | ---- | -128.83%-2.93M |
| Investment loss (gain) | ---- | ---- | ---- | ---- | ---- | ---82.04M | ---- | ---- | ---- | ---- |
| Attributable subsidiary (profit) loss | ---- | -107.30%-1.45M | ---- | 1,371.25%19.9M | ---- | -110.75%-1.57M | ---- | 30.12%14.56M | ---- | 154.64%11.19M |
| Impairment and provisions: | ---- | 999.52%119.71M | ---- | -98.15%10.89M | ---- | 1,694.58%589.75M | ---- | 56.40%32.86M | ---- | 7,485.56%21.01M |
| -Impairment of property, plant and equipment (reversal) | ---- | 301.60%3M | ---- | -94.62%748K | ---- | 60.08%13.91M | ---- | 172.18%8.69M | ---- | --3.19M |
| -Impairment of goodwill | ---- | ---- | ---- | ---- | ---- | --566.46M | ---- | ---- | ---- | ---- |
| -Other impairments and provisions | ---- | 1,051.01%116.7M | ---- | 7.99%10.14M | ---- | -61.16%9.39M | ---- | 35.66%24.18M | ---- | 6,333.21%17.82M |
| Revaluation surplus: | ---- | -105.01%-1.11M | ---- | -51.75%22.05M | ---- | 246.27%45.69M | ---- | ---31.24M | ---- | ---- |
| -Derivative financial instruments fair value (increase) | ---- | ---- | ---- | -49.86%23.75M | ---- | 261.90%47.38M | ---- | ---29.26M | ---- | ---- |
| -Other fair value changes | ---- | 35.23%-1.11M | ---- | -1.31%-1.71M | ---- | 14.73%-1.68M | ---- | ---1.98M | ---- | ---- |
| Asset sale loss (gain): | ---- | -368.31%-381K | ---- | -89.69%142K | ---- | -58.02%1.38M | ---- | -91.78%3.28M | ---- | 6,041.54%39.92M |
| -Loss (gain) from sale of subsidiary company | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --39.99M |
| -Loss (gain) on sale of property, machinery and equipment | ---- | 20.12%3.2M | ---- | -57.51%2.66M | ---- | -25.44%6.27M | ---- | 564.14%8.41M | ---- | 94.77%1.27M |
| -Loss (gain) from selling other assets | ---- | -41.99%-3.58M | ---- | 48.45%-2.52M | ---- | 4.60%-4.89M | ---- | -282.69%-5.13M | ---- | ---1.34M |
| Depreciation and amortization: | ---- | -16.99%93.22M | ---- | -22.36%112.3M | ---- | -13.49%144.64M | ---- | -5.68%167.19M | ---- | 495.42%177.25M |
| -Depreciation | ---- | -16.99%93.22M | ---- | -22.36%112.3M | ---- | -13.49%144.64M | ---- | -5.68%167.19M | ---- | 517.08%177.25M |
| -Other depreciation and amortization | ---- | -484.26%-1.15M | ---- | 93.31%-197K | ---- | -4.99%-2.95M | ---- | 38.52%-2.81M | ---- | -50,611.11%-4.56M |
| Financial expense | ---- | -9.03%47.17M | ---- | 8.13%51.86M | ---- | -8.34%47.96M | ---- | -13.52%52.33M | ---- | 793.59%60.51M |
| Exchange Loss (gain) | ---- | 155.34%171K | ---- | -120.52%-309K | ---- | 176.92%1.51M | ---- | -152.41%-1.96M | ---- | 79.18%3.74M |
| Special items | ---- | -59.49%4.83M | ---- | 253.32%11.92M | ---- | -72.45%3.37M | ---- | -34.22%12.25M | ---- | 170.52%18.62M |
| Adjustment items | ---- | -484.26%-1.15M | ---- | 93.31%-197K | ---- | -4.99%-2.95M | ---- | 38.52%-2.81M | ---- | -333.02%-4.56M |
| Operating profit before the change of operating capital | ---- | 122.06%102.45M | ---- | -43.10%46.14M | ---- | -4.42%81.09M | ---- | -60.23%84.85M | ---- | 1,491.24%213.35M |
| Change of operating capital | ||||||||||
| Inventory (increase) decrease | ---- | -92.43%834K | ---- | 480.53%11.02M | ---- | -180.54%-2.9M | ---- | 117.21%3.6M | ---- | -337.69%-20.91M |
| Accounts receivable (increase)decrease | ---- | ---- | ---- | ---- | ---- | -104.98%-168K | ---- | --3.38M | ---- | ---- |
| Accounts payable increase (decrease) | ---- | -88.93%-9.37M | ---- | 68.45%-4.96M | ---- | -187.90%-15.72M | ---- | 5.74%17.88M | ---- | 110.29%16.91M |
| Special items for working capital changes | ---- | -132.39%-9.94M | ---- | 708.40%30.69M | ---- | -42.98%3.8M | ---- | 138.99%6.66M | ---- | -121.54%-17.08M |
| Cash from business operations | -67.45%15.56M | 1.31%83.98M | -2.92%47.8M | 25.39%82.89M | -11.74%49.24M | -43.18%66.11M | 40.67%55.79M | -39.49%116.36M | -51.76%39.66M | 405.56%192.28M |
| Other taxs | -821.35%-820K | 81.29%-78K | ---89K | 79.66%-417K | ---- | 32.05%-2.05M | 100.45%22K | -433.37%-3.02M | -17.67%-4.85M | 112.93%905K |
| Interest received - operating | 0.00%53K | 48.30%522K | -62.68%53K | 144.44%352K | 54.35%142K | -34.84%144K | -69.23%92K | -14.67%221K | -60.24%299K | 37.04%259K |
| Interest paid - operating | 9.09%-150K | -3.06%-943K | 38.20%-165K | 5.48%-915K | -13.62%-267K | -46.22%-968K | -190.12%-235K | -99.40%-662K | 99.12%-81K | -39.50%-332K |
| Net cash from operations | -69.24%14.64M | 1.92%83.48M | -3.08%47.6M | 29.54%81.91M | -11.78%49.12M | -43.99%63.24M | 58.91%55.67M | -41.54%112.9M | -49.68%35.03M | 375.97%193.12M |
| Cash flow from investment activities | ||||||||||
| Interest received - investment | -50.08%295K | -56.21%525K | 31.04%591K | -53.62%1.2M | -49.21%451K | 23.27%2.59M | 23.16%888K | -2.28%2.1M | -32.99%721K | 126.37%2.15M |
| Dividend received - investment | ---- | --3.43M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Restricted cash (increase) decrease | ---- | 95.04%-37K | ---- | 22.37%-746K | ---- | ---961K | ---- | ---- | ---- | ---- |
| Loan receivable (increase) decrease | ---9M | -43.02%-10M | ---- | -355.18%-6.99M | 73.63%-3.14M | 130.25%2.74M | -626.46%-11.91M | -90.49%1.19M | 28.32%-1.64M | -83.96%12.51M |
| Sale of fixed assets | -65.57%21K | -41.28%404K | -73.36%61K | 33.85%688K | -19.93%229K | 48.13%514K | 160.00%286K | -88.81%347K | -96.64%110K | 1,208.44%3.1M |
| Purchase of fixed assets | -55.53%-6.85M | 27.52%-11.8M | 27.50%-4.4M | 50.61%-16.28M | 66.05%-6.07M | -0.68%-32.97M | -136.79%-17.88M | 45.21%-32.74M | 69.99%-7.55M | -73.41%-59.77M |
| Purchase of intangible assets | ---- | 18.27%-85K | ---- | 92.11%-104K | ---- | -3,665.71%-1.32M | ---23K | 97.54%-35K | ---- | 10.28%-1.42M |
| Sale of subsidiaries | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---7.24M |
| Acquisition of subsidiaries | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 79.43%-139.5M |
| Recovery of cash from investments | 131.49%68.98M | -64.37%69.59M | -50.10%29.8M | 21.04%195.31M | -69.92%59.72M | 9.83%161.36M | 210.74%198.52M | 63.06%146.92M | -29.58%63.89M | 14.62%90.1M |
| Cash on investment | -235.77%-48.45M | 86.57%-27.53M | 81.91%-14.43M | -28.24%-204.92M | 63.50%-79.76M | -37.45%-159.8M | -175.61%-218.53M | 17.96%-116.26M | 29.03%-79.29M | -51.07%-141.71M |
| Other items in the investment business | 881.31%1.05M | ---- | -88.87%107K | ---- | -15.85%961K | 3,703.58%20.16M | --1.14M | -91.51%530K | ---- | 4,207.59%6.25M |
| Net cash from investment operations | -48.34%6.06M | 176.93%24.51M | 142.48%11.73M | -314.72%-31.86M | 41.89%-27.61M | -475.42%-7.68M | -99.93%-47.51M | 100.87%2.05M | 86.77%-23.77M | 63.77%-235.53M |
| Net cash before financing | -65.11%20.7M | 115.73%107.99M | 175.90%59.33M | -9.89%50.06M | 163.59%21.5M | -51.67%55.55M | -27.59%8.16M | 371.00%114.94M | 110.24%11.27M | 94.11%-42.42M |
| Cash flow from financing activities | ||||||||||
| New borrowing | 5.00%12.6M | -25.58%12M | -10.91%12M | -5.15%16.13M | 3.22%13.47M | 13.33%17M | 30.50%13.05M | 200.00%15M | --10M | --5M |
| Refund | 25.78%-11M | 10.42%-16.13M | 1.53%-14.82M | -11.11%-18M | -5.61%-15.05M | -224.00%-16.2M | -630.77%-14.25M | 0.00%-5M | 61.00%-1.95M | 85.15%-5M |
| Dividends paid - financing | ---1.58M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 98.01%-363K |
| Absorb investment income | --279K | ---- | ---- | ---- | ---- | 270.10%4.06M | --2M | 4.48%1.1M | ---- | --1.05M |
| Net cash from financing operations | 58.37%-23.75M | -34.80%-106.28M | -0.70%-57.06M | 30.92%-78.84M | 8.89%-56.66M | 7.48%-114.13M | -94.54%-62.19M | 2.84%-123.36M | 49.57%-31.97M | -120.68%-126.97M |
| Effect of rate | 141.67%20K | -155.34%-171K | -107.13%-48K | 111.93%309K | 1,939.39%673K | -396.68%-2.59M | 106.64%33K | 154.43%873K | -114.67%-497K | -115.63%-1.6M |
| Net Cash | -234.60%-3.05M | 105.94%1.71M | 106.45%2.27M | 50.87%-28.78M | 34.93%-35.16M | -595.97%-58.58M | -161.02%-54.03M | 95.03%-8.42M | 88.06%-20.7M | -59.77%-169.39M |
| Begining period cash | 4.51%35.64M | -45.51%34.1M | -45.51%34.1M | -49.43%62.57M | -49.43%62.57M | -5.75%123.74M | -5.75%123.74M | -56.57%131.29M | -56.57%131.29M | -24.06%302.28M |
| Cash at the end | -10.23%32.6M | 4.51%35.64M | 29.31%36.32M | -45.51%34.1M | -59.73%28.09M | -49.43%62.57M | -36.65%69.74M | -5.75%123.74M | -16.79%110.09M | -56.57%131.29M |
| Cash balance analysis | ||||||||||
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.